NasdaqGM:KALVBiotechs
Assessing KalVista Pharmaceuticals (KALV) Valuation After A Strong Year Of Shareholder Returns
Recent performance snapshot
KalVista Pharmaceuticals (KALV) has drawn fresh attention after a strong stretch for the stock, with the price at US$26.87 and total return figures over the past year and past 3 months standing out.
See our latest analysis for KalVista Pharmaceuticals.
For context, the share price has shown strong momentum over the past year, with a 90 day share price return of 67.31% and a 1 year total shareholder return of 127.71%. However, the 5 year total shareholder return of...